Skip to main content
Download PDF

Aldosterone-progesterone relationship in sexually intact Chihuahua bitches

BMC Veterinary Research volume 19, Article number: 144 (2023) Cite this article

Abstract

Background

Aldosterone represents an important target of heart failure therapy and may be a valuable indicator of the renin-angiotensin-aldosterone system activity. However, its assessment might be challenging because of the effect of individual factors. In a recent study, intact female dogs showed the highest value of urinary aldosterone-to-creatinine ratio (UAldo:C) compared to other sex categories. In humans and rodents, an influence of progesterone has been reported by several studies. To our knowledge, the relationship between aldosterone and progesterone has not yet been investigated in dogs. The aim of this prospective study was to investigate this relationship in sexually intact Chihuahua females, measuring both hormones twice in the same bitch, that is in anoestrus when progesterone concentrations are baseline and in dioestrus when they are high.

Results

The study population consisted of 14 sexually intact Chihuahua bitches. Serum progesterone (34.06 (21.17–44.90) vs. 0.19 [0.13–0.38] ng/ml; P < 0.001) and urinary aldosterone (9886.98 ± 5735.22 vs. 5005.72 ± 2127.73 pg/ml; P = 0.01) were significantly higher in dioestrus compared to anoestrous. Urinary aldosterone-to-creatinine ratio was higher in dioestrus compared to anoestrus (4.16 [3.17–6.80] vs. 3.39 ± 1.64 µg/g), but it did not reach the statistical significance (P = 0.056). Serum progesterone showed a moderate positive correlation with urinary aldosterone (ρ = 0.638, P < 0.001) and UAldo:C (ρ = 0.516, P = 0.005).

Conclusions

The results of the present study suggest the existence of a progesterone-aldosterone relationship in canine species, indicating that sex and phase of reproductive cycle should be taken into account when interpreting aldosterone concentrations. Further studies are needed to confirm these results on a larger canine population and to identify the underlying mechanisms in this species.

Peer Review reports

Introduction

Chronic renin-angiotensin-aldosterone system (RAAS) activation promotes and perpetuates the congestive heart failure (CHF) syndrome [1, 2]. Prolonged and excessive aldosterone secretion leads to several harmful cardiovascular effects (e.g., volume and pressure overload, inflammation, fibrosis), and aldosterone has become an important target of CHF therapy [1, 3, 4, 5, 6]. The assessment of RAAS activity in dogs with heart diseases could improve their clinical and therapeutic management. Since aldosterone represents the terminal hormone of the cascade, its assessment covers the RAAS alternative pathways and the aldosterone breakthrough phenomenon [1, 7, 8]. Thus, it holds potential as a valuable indicator of a patient’s overall RAAS activity. However, the interpretation of this marker might be challenging. In a recent study in dogs, aldosterone levels appeared to be affected by individual factors. In particular, Chihuahuas and sexually intact females showed the highest values of urinary aldosterone-to-creatinine ratio (UAldo:C) among breed and sex categories respectively [9]. The interbreed variability might be related to the polymorphisms of genes encoding for RAAS components, as previously suggested [8, 10]. Regarding gender, RAAS activity has been suggested to be affected by sexual hormones. A rise in aldosterone levels have been reported to occur during the luteal phase of menstrual cycle in women and progesterone has been found to be a high affinity antagonist for human mineralocorticoid receptors (MR), preventing aldosterone interaction. Thus, the increase in serum and urinary aldosterone levels likely occurs because of MRs occupation and compensatory activation of RAAS [11, 12, 13]. However, progesterone might contribute to the rise of aldosterone concentration even through RAAS-independent mechanisms, such as directly stimulating aldosterone production from zona glomerulosa [11, 14]. In dogs, an increase in RAAS activity during pregnancy has been suggested [15, 16], but, to our knowledge, the relationship between progesterone and aldosterone levels has not yet been investigated in this species. The aim of this prospective study was to investigate the relationship between progesterone and aldosterone in sexually intact Chihuahua bitches, measuring these hormones in anoestrus and dioestrus (i.e., low and high progesterone state respectively).

Results

Animals

The study population consisted of 14 sexually intact Chihuahua females. The mean age was 3.71 ± 1.55 years and the mean body weight was 2.82 ± 0.41 kg; 6 out of 14 dogs had a Body Condition Score (BCS) of 4/9 and 8 out of 14 dogs had a BCS of 5/9. All dogs were fed a normal-sodium diet (0.34% [OASY One Animal Protein Adult/Small Mini Salmon; OASY, Republic of San Marino] and 0.4% sodium [Royal Canin Mini Adult; Royal Canin, Aimargues, France]). The mean systolic arterial pressure was 135.14 ± 16.92 mmHg. Complete blood count (CBC), biochemical profile and urinalysis were unremarkable in all dogs. Cardiac auscultation was unremarkable in 11/14 dogs; 2 dogs presented a I/VI grade left apical systolic murmur and 1 dog an II/VI grade left apical systolic murmur. Echocardiography was unremarkable in 11 dogs (American College of Veterinary Internal Medicine [ACVIM] stage A), while 3 dogs were diagnosed with Myxomatous Mitral Valve Disease (MMVD) ACVIM stage B117. Dogs in dioestrus were evaluated between 23 and 48 days after the onset of serosanguinous vulvar discharge. Dogs in anoestrus were evaluated between 99 and 302 days after the last oestrus and before the subsequent proestrus. Phases of reproductive cycle (anoestrus and dioestrus) were confirmed by vaginal cytology in all dogs.

Hormone measurements

Results of hormone measurements are reported in Table 1. Serum progesterone and urinary aldosterone were significantly higher in dioestrus compared to anoestrous. Urinary aldosterone-to-creatinine ratio was higher in dioestrus compared to anoestrus, but it did not reach the statistical significance. N-Terminal pro-B-type natriuretic peptide (NT-proBNP) was not significantly different between anoestrous and dioestrus.

Table 1 Hormones measurements in anoestrus and dioestrus
Full size table

In total sample (anoestrus + dioestrus), serum progesterone showed a positive moderate correlation with urinary aldosterone (ρ = 0.638, P < 0.001) and UAldo:C (ρ = 0.516, P = 0.005). N-Terminal pro-B-type natriuretic peptide was not significantly different between anoestrus and dioestrus and no significant correlations were found between NT-proBNP and serum progesterone, urinary aldosterone and UAldo:C.

Urinalysis

Results of urinalysis are reported in Table 2. Urinary protein-to-creatinine ratio (UP/UC) was significantly higher in anoestrus compared to dioestrus. Urinary creatinine (UC) was significantly higher in dioestrus compared to anoestrus. No significant differences in urine specific gravity (USG) and urinary protein (UP) were found between the two phases of oestrus cycle.

Table 2 Comparison of urinary parameters between anoestrus and dioestrus
Full size table

Discussion

The results of the present study suggest the existence of a progesterone-aldosterone relationship in canine species.

As expected, progesterone significantly increased in dioestrus compared to anestrus [17]. Urinary aldosterone showed a significant parallel increase and UAldo:C raised in dioestrus with a P value close to significance (0.056). Moreover, urinary aldosterone and UAldo:C showed a significant positive correlation with progesterone in total population.

In women, the luteal phase of the menstrual cycle is characterized by increased levels of progesterone and oestradiol, and a rise in aldosterone concentration during this period has been reported by several studies [11, 12, 18,19,20]. Progesterone represents a high-affinity antagonist of MRs in humans and rats, acting as a competitive inhibitor of aldosterone and inducing natriuresis [13, 14, 18, 21,22,23,24]. Because of these properties, high levels of progesterone likely lead to an increase in aldosterone concentrations because of the receptor occupation and the compensatory activation of the RAAS [11, 19, 20, 24, 25, 26]. However, even a RAAS-independent mechanism has been suggested. Szmuilowicz et al. (2006) reported an increase in aldosterone levels during the luteal phase in women without a concurrent increase in plasma renin activity and angiotensin-II [11]. In the same study, they found that the incubation of rat zona glomerulosa cells with progesterone caused a significant increase in aldosterone production compared to the incubation with vehicle alone [11]. A similar result has been obtained with human adrenocortical cells [27]. These findings suggest that progesterone directly stimulate adrenal aldosterone production. Progesterone receptors has been found in the adrenal capsular cells of female mice [28] and in human adrenocortical cells [27], and it has been hypothesized that this hormone might influence aldosterone secretion through its own receptors [11]. A second hypothesis is that increased levels of progesterone correspond to increased levels of substrate for 21-hydroxylase in the adrenal cells, since progesterone represent a precursor in the aldosterone biosynthetic pathway [11, 29]. A similar mechanism has been already hypothesized for the positive relationship between progesterone and cortisol reported in peripartum bitches and naturally cycling women [26, 30]. However, the role of progesterone as a direct stimulator of aldosterone secretion remains subject of debate, since conflicting results have been reported in vitro [31].

Interestingly, progesterone has different properties in other species. In cartilaginous and ray-finned fish, in which aldosterone is not synthetized, progesterone represents a physiological activator of MRs [13]. Mineralocorticoid receptors preceded aldosterone by millions of years, and they evolved from an ancestral protein in common with glucocorticoid, progesterone and androgen receptors. Aldosterone appeared for the first time in lungfish, which represent a transition from aquatic to terrestrial life [13, 32]. The role of progesterone as MR activator was lost in amphibians, alligators, rodents and humans [13]. Unexpectedly, progesterone activates MR in chicken and the reason remains unknown at this time, since the receptor has molecular characteristics similar to that of humans [13, 33]. Currently, a mutant human MR represents the only other case of MR activated by progesterone in terrestrial vertebrates [34]. In dogs, previous studies suggested an increase in RAAS activity in relation to pregnancy/oestrous cycle [15, 16, 19], but, to our knowledge, this is the first study that investigated the relationship between progesterone and aldosterone in canine species. Such as humans and rodents, dogs belong to mammals class and, from an evolution perspective, it could be presumed that similar mechanisms regulate the interactions among MR, progesterone and aldosterone. However, Johnson et al. (1970) found that natriuresis did not occur after progesterone infusion in healthy dogs [35], raising doubts about the role of progesterone as MR antagonist in this species. The underlying mechanisms are still to be determined and further investigations are warranted in dogs, especially in the molecular and cellular field.

Szmuilowicz et al. (2006) showed a direct correlation between aldosterone and progesterone among women receiving a high-sodium diet, but no differences in aldosterone levels between follicular and luteal phase were found among women in a low-sodium regimen [11]. Although these results confirm that progesterone is responsible of aldosterone increase, they also indicate that natremia remains a primary modulator of RAAS activity and it likely overwhelms the role of progesterone in case of sodium restriction [11]. In the present study, all dogs included were fed two type of normal-sodium commercial diet throughout the reproductive cycle and their sodium content was superimposable. Thus, it can be excluded that sodium intake influenced the difference in aldosterone levels between anoestrus and dioestrus in the present study.

In a previous study, Chihuahua showed significantly higher UAldo:C compared to other breeds [9]. Polymorphism of angiotensin converting enzyme has been reported in dogs, with wide prevalence variability among breeds 36. This gene variant has been associated with higher aldosterone levels and aldosterone breakthrough incidence in dogs [8]. In the present study, Chihuahua breed was chosen as inclusion criterion in order to eliminate the breed-related variability of aldosterone. It cannot be excluded that also the relationship between aldosterone and sexual hormones may be breed-related, and further investigation on multiple breeds are warranted.

Urinary aldosterone-to-creatinine ratio was higher in dioestrus compared to anoestrus, but it was not statistically different (P = 0.056) between the two phases. However, the following aspects should be taken into consideration: a small sample size (i.e., higher probability of type-II error) and the fact that urinary creatinine was significantly higher in dioestrus compared to anoestrus, in face of a superimposable USG. Urinary creatinine is one of the most-used correction factors to adjust several urinary biomarkers for dilution in spot urine samples [37]. The rationale is that UC excretion is constant [38]. However, creatinine clearance and UC excretion might be influenced by physiological changes [39]. For example, these parameters appeared significantly higher in mid-luteal phase (high oestrogen and high progesterone state) compared to pre-ovulatory phase (high oestrogen and low progesterone state) in women [40]. Variations of urinary creatinine, creatinine clearance and glomerular filtration rate have been reported also over the course of pregnancy [39, 41, 42]. Thus, it cannot be excluded that changes in UC excretion between anoestrus and dioestrus may have affected the UAldo:C results in the present study. To our knowledge, there are no reports about the variability of UC excretion over the reproductive cycle in dogs and further investigations are warranted to confirm this hypothesis.

N-Terminal pro-B-type natriuretic peptide was not significantly different between anoestrus and dioestrus and did not show any correlation with progesterone. Previous studies in dogs reported significantly higher NT-proBNP in intact females than intact males [43, 44], in agreement with studies in people, where women showed significantly higher NT-proBNP than men [45,46,47,48,49]. No differences were found between intact and neutered female dogs, as well as between intact and neutered males [44]. In women, NT-proBNP was found to be significantly higher in luteal and follicular phase than in midcycle phase [50]. In humans, the mechanisms behind the influence of gender on natriuretic peptides (NP) are still subject of debate. Initially, the difference between genders was attributed to oestrogens (and, in part, to progesterone), which could have both a direct and indirect stimulatory effect on NPs [47, 50,51,52]. More recently, the role of gender has been primarily related to testosterone, which has been found to be inversely correlated with NPs likely because of a suppressive effect on their release [45, 50, 53]. However, controversial results have been reported for both oestrogens and testosterone. It is likely that both hormones contribute to the regulation and the determination of NPs levels through the sum of their effects [50]. Even the role of progesterone is not clear because of conflicting results [50, 51, 54,55,56]. In dogs, no differences were found between intact and neutered female [44], but, to our knowledge, there are no reports about NPs levels in different phase of reproductive cycle and their correlation with sex hormones. Based on the results of the present study, NT-proBNP seems not to be affected by progesterone and not to significantly vary between anoestrus and dioestrus. However, oestrogens and testosterone were not measured, and the other phases of reproductive cycle were not evaluated. Thus, further investigations are warranted in dogs to better define the variation of NPs through the entire cycle and their relationship with sex hormones.

The present study has several limitations. First of all, the small sample size limits the strength and the accuracy of the results; contributors encourage further studies on a large canine population, and even in other breeds, to verify their replicability. Secondly, oestrogens were not evaluated and a possible influence of these hormones on aldosterone could have been missed. However, oestrogens levels in dioestrus are low [17] and their potential effect on RAAS should be limited during this phase. Thirdly, serum sodium and potassium levels can affect RAAS activity [57], and they were not assessed in the present study. Fourthly, assessment of other RAAS components and urinary sodium would help obtain a better understanding of the aldosterone-progesterone relationships. Lastly, although the time of urine collection was restricted between 10 am and 2 pm, an influence of urinary aldosterone and UC circadian variations on the values obtained in the present study cannot be excluded [58, 59].

Conclusion

These results suggest the existence of a progesterone-aldosterone relationship in canine species, indicating that gender and phase of oestrous cycle should be taken into account for a correct interpretation of aldosterone levels in dogs. Mechanisms underlying this correlation in dogs might be similar to those reported for humans and rodents, that are the MRs antagonism by progesterone with the consequent compensatory RAAS activation, and a direct stimulation of aldosterone production by progesterone as well. Further studies are needed both to confirm these results on a larger canine population and to identify the mechanisms behind this relationship in this species.

Materials and methods

Animals and study timeline

This prospective study was conducted in accordance with guidelines of the Animal Welfare Organisation of the Università degli Studi di Milano (approval number 2/ 2016) and with informed consent of the owners. Subjects enrolled in this study were recruited among private owned breeding dogs referred to the Veterinary Teaching Hospital – University of Milan (January-December 2021) for cardiological and reproductive screening/monitoring. All procedures to which patients have been subjected were part of their screening/monitoring program. Adjunctive analyses on serum/plasma were performed on leftover samples, while urine analyses were performed on free-catch samples.

Inclusion and exclusion criteria

To be enrolled in the study, dogs had to meet the following criteria: Chihuahua breed, intact female and older than 12 months. All dogs had to be either healthy or affected by MMVD ACVIM stage B117. Subjects with any other known disease or subjected to any pharmacological treatment at the time of examinations were excluded.

All dogs included in the study had to undergo two examinations as part of their reproductive monitoring program: the first one during anoestrus (i.e., at basal levels of progesterone) and the second one during following dioestrus (i.e., at high levels of progesterone). During anoestrus, each dog underwent indirect blood pressure measurement, complete physical examination, echocardiography, vaginal cytology, blood sampling (for CBC, biochemistry profile and serum progesterone), collection of a free-catch urine sample (for urinalysis and urinary aldosterone) and assessment of plasma NT-proBNP. In dioestrus, the following procedures were repeated: vaginal cytology, blood sampling (for serum progesterone), collection of a free-catch urine sample (for urinalysis and urinary aldosterone) and assessment of plasma NT-proBNP. Diet information was also collected. Dogs with no abnormalities on medical history and aforementioned procedures were considered healthy. Patients diagnosed with MMVD by echocardiography were classified as stage B1 following the criteria of the ACVIM guidelines [60].

Systolic arterial pressure and echocardiography

Non-invasive arterial pressure measurements were obtained and interpreted based on published guidelines [61], using a veterinary high-definition oscillatory device Footnote 1.

Echocardiography was performed by two experienced echocardiographers, using an ultrasonographic unit (Esaote MyLabOmega) equipped with two multifrequency phased array probes (1–9 and 2–5 Mhz respectively). Each dog underwent a complete echocardiographic examination, in accordance with published standards [62]. All dogs were conscious during the procedure.

Sample collection, storage and analysis

Blood sampling was performed by venepuncture on fasted dogs (i.e., at least 6–8 h after meal), and blood was immediately collected into EDTA and serum gel tubes.

Blood collected into EDTA tubes was used for CBC. Samples were then immediately centrifugated at 3750 rpm for 5 min and plasma was stored at -80 °C. Refrigerated plasma samples were sent at IDEXX laboratory (Korwestheim, Germany) for plasma NT-proBNP measurement by a second-generation Enzyme-linked Immunosorbent Assay (ELISA)Footnote 2.

Blood collected into serum gel tubes was left to clot at room temperature for 30 min, and then it was centrifugated at 3750 rpm for 5 min. Serum was used for biochemical analysis (urea, creatinine, glucose, total protein, albumin, alanine aminotransferase, alkaline phosphatase). Residual serum was stored at -80 °C and then submitted for the determination of progesterone.

Urine samples were collected by spontaneous micturition and standard urinalysis was performed (i.e., dipstick chemistry test and USG by refractometer). After centrifugation at 1250 rpm for 5 min, supernatant was used for urinary protein and urinary creatinine assessment by Pyrogallol Red Method. Values of UP/UC below 0.5 were considered normal [63]. Residual supernatant was stored at -80 °C for subsequent determination of urinary aldosterone.

Urinary aldosterone concentrations were assessed by a commercially available species-independent ELISA kit Footnote 3, following the manufacturer’s recommendations. The ELISA kit was previously validated for the measurement of aldosterone in dog urine after acid hydrolysis [9].

Serum progesterone concentrations were determined by an Enzyme-linked Fluorescent Assay method (Enzyme-linked Fluorescent Assay) Footnote 4 validated in dogs [64].

Statistical analysis

Statistical analysis was performed with commercially available statistical software (IBM SPSS® Statistics 27). The Kolmogorov-Smirnov test was used to assess normality. Parametric variables were reported as mean ± standard deviation (SD) and compared by paired-sample t-test; nonparametric variables were reported as median and interquartile range (IQR) and compared by paired-sample Wilcoxon signed-rank test. To compare a parametric variable with a nonparametric one, paired-sample Wilcoxon signed-rank test was used. Correlations among variables were explored by the Pearson correlation coefficient (ρ), and results were interpreted as follows: ρ ≤ 0.03 weak correlation, ρ > 0.3 and ≤ 0.7 moderate correlation, ρ > 0.7 strong correlation. A P value < 0.05 was considered statistically significant.

A constant value corresponding to half of the limit of detection (LOD) was assigned to patients with serum progesterone and plasma NT-proBNP below the LOD (0.25 ng/ml and 250 pmol/l respectively).

Data Availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Notes

  1. VET-HDO ®- MONITOR, S + B medVET GmbH, Babenhausen, Germany.

  2. NT-proBNP: ELISA Cardiopet proBNP test, IDEXX Laboratories, Westbrook, ME.

  3. Enzo Life Sciences Aldosterone ELISA kit, Enzo Life Sciences Inc., Farmingdale, NY, USA.

  4. MiniVidas automated analyser, bioMérieux, Marcy-l’Étoile, France.

Abbreviations

RAAS:

Renin-angiotensin-aldosterone system

CHF:

Congestive heart failure

UAldo:

C:Urinary aldosterone-to-creatinine ratio

MR:

Mineralocorticoid receptor

BCS:

Body Condition Score

CBC:

Complete Blood Count

ACVIM:

American College of Veterinary Internal Medicine

MMVD:

Myxomatous mitral valve disease

NT-proBNP:

N-Terminal pro-B-type natriuretic peptide

UP/UC:

Urinary protein-to-creatinine ratio

UC:

Urinary creatinine

UP:

Urinary protein

USG:

Urine specific gravity

NP:

Natriuretic peptide

SD:

Standard deviation

IQR:

Interquartile range

LOD:

Limit of detection

ELISA:

Enzyme-linked immunosorbent assay

References

  1. Ames MK, Atkins CE, Pitt B. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;1–20.

  2. Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin Small Anim. 2004;34:1105–26.

    Article  Google Scholar 

  3. Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res. 2004;61:663–70.

    Article  CAS  PubMed  Google Scholar 

  4. Leopold JA. Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling. Circulation. 2011;124:e466–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hezzell MJ, Boswood A, Chang YM, et al. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease. Am J Vet Res. 2012;73:1765–74.

    Article  CAS  PubMed  Google Scholar 

  6. Bernay F, Bland JM, Häggström J, et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med. 2010;24:331–41.

    Article  CAS  PubMed  Google Scholar 

  7. Ames MK, Atkins CE, Eriksson A, et al. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease. J Vet Cardiol. 2017;19:218–27.

    Article  CAS  PubMed  Google Scholar 

  8. Adin D, Atkins C, Domenig O, et al. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism. J Vet Intern Med. 2020;34:600–6.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Galizzi A, Bagardi M, Stranieri A, et al. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease. BMC Vet Res. 2021;17(1):15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Meurs KM, Stern JA, Atkins CE, et al. Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism. J Renin Angiotensin Aldosterone Syst. 2017;18:1470320317737184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Szmuilowicz ED, Adler GK, Williams JS, et al. Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrinol Metab. 2006;91:3981–7.

    Article  CAS  PubMed  Google Scholar 

  12. Hirshoren N, Tzoran I, Makrienko I, et al. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab. 2002;87:1569–75.

    Article  CAS  PubMed  Google Scholar 

  13. Baker ME, Katsu Y, Progesterone. An enigmatic ligand for the mineralocorticoid receptor. Biochem Pharmacol. 2020;177:113976.

    Article  CAS  PubMed  Google Scholar 

  14. Braley LM, Menachery AI, Yao T, et al. Effect of progesterone on aldosterone secretion in rats. Endocrinology. 1996;137:4773–8.

    Article  CAS  PubMed  Google Scholar 

  15. Robb CA, Davis JO, Johnson JA, et al. Mechanisms regulating the renal excretion of sodium during pregnancy. J Clin Invest. 1970;49(5):871–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Milani C, Rota A, Olsson U, et al. Serum concentration of mineralocorticoids, glucocorticoids, and sex steroids in peripartum bitches. Domest Anim Endocrinol. 2021;74:106558.

    Article  CAS  PubMed  Google Scholar 

  17. Concannon PW. Reproductive cycles of the domestic bitch. Anim Reprod Sci. 2011;124(3–4):200–10.

    Article  CAS  PubMed  Google Scholar 

  18. Ahmed AH, Gordon RD, Ward G, et al. Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study. Clin Endocrinol (Oxf). 2015;83(3):303–7.

    Article  CAS  PubMed  Google Scholar 

  19. Sundsfjord JA, Aakvaag A. Plasma renin activity, plasma renin substrate and urinary aldosterone excretion in the menstrual cycle in relation to the concentration of progesterone and oestrogens in the plasma. Acta Endocrinol (Copenh). 1972;71(3):519–29.

    CAS  PubMed  Google Scholar 

  20. Michelakis AM, Yoshida H, Dormois JC. Plasma renin activity and plasma aldosterone during the normal menstrual cycle. Am J Obstet Gynecol. 1975;123(7):724–6.

    Article  CAS  PubMed  Google Scholar 

  21. Wambach G, Higgins JR. Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors. Endocrinology. 1978;102(6):1686–93.

    Article  CAS  PubMed  Google Scholar 

  22. Landau RL, Lugibihl K. Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab. 1958;18(11):1237–45.

    Article  CAS  PubMed  Google Scholar 

  23. Myles K, Funder JW. Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am J Physiol. 1996;270(4 Pt 1):E601–607.

    CAS  PubMed  Google Scholar 

  24. Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids. 1996;61(4):166–71.

    Article  CAS  PubMed  Google Scholar 

  25. Katz FH, Romfh P. Plasma aldosterone and renin activity during the menstrual cycle. J Clin Endocrinol Metab. 1972;34(5):819–21.

    Article  CAS  PubMed  Google Scholar 

  26. De Cramer KGM, Nöthling JO. The precision of predicting the time of onset of parturition in the bitch using the level of progesterone in plasma during the preparturient period. Theriogenology. 2018;107:211–18.

    Article  PubMed  Google Scholar 

  27. Nicolini G, Balzan S, Morelli L, et al. LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma. Horm Metab Res. 2014;46(5):318–21.

    CAS  PubMed  Google Scholar 

  28. Uotinen N, Puustinen R, Pasanen S, et al. Distribution of progesterone receptor in female mouse tissues. Gen Comp Endocrinol. 1999;115(3):429–41.

    Article  CAS  PubMed  Google Scholar 

  29. Burwell LR, Davis WW, Bartter FC. Studies on the loci of action of stimuli to the biogenesis of aldosterone. Proc R Soc Med. 1969;62(12):1254–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Herrera AY, Nielsen SE, Mather M. Stress-induced increases in progesterone and cortisol in naturally cycling women. Neurobiol Stress. 2016;3:96–104.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Vecchiola A, Lagos CF, Fuentes CA, et al. Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro. Reprod Biol Endocrinol. 2013;11:76.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Funder JW. Aldosterone and Mineralocorticoid Receptors—Physiology and pathophysiology. Int J Mol Sci. 2017;18(5):1032.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Katsu Y, Oka K, Baker ME. Evolution of human, chicken, alligator, frog, and zebrafish mineralocorticoid receptors: allosteric influence on steroid specificity. Sci Signal. 2018;11(537):eaao1520.

    Article  PubMed  Google Scholar 

  34. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289(5476):119–23.

    Article  CAS  PubMed  Google Scholar 

  35. Johnson JA, Davis JO, Baumber JS, et al. Effects of estrogens and progesterone on electrolyte balances in normal dogs. Am J Physiol. 1970;219(6):1691–7.

    Article  CAS  PubMed  Google Scholar 

  36. Adin DB, Atkins CE, Friedenberg SG, et al. Prevalence of an angiotensin-converting enzyme gene variant in dogs. Canine Med Genet. 2021;8(1):6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Gardner SY, Atkins CE, Rausch WP, et al. Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio. J Vet Cardiol. 2007;9(1):1–7.

    Article  PubMed  Google Scholar 

  38. Waikar SS, Sabbisetti VS, Bonventre JV. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int. 2010;78(5):486–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Lee G, Kim S, Park H, et al. Variability of urinary creatinine, specific gravity, and osmolality over the course of pregnancy: implications in exposure assessment among pregnant women. Environ Res. 2021;198:110473.

    Article  CAS  PubMed  Google Scholar 

  40. Phipps WR, Duncan AM, Merz BE, et al. Effect of the menstrual cycle on creatinine clearance in normally cycling women. Obstet Gynecol. 1998;92(4 Pt 1):585–8.

    CAS  PubMed  Google Scholar 

  41. Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209–14.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Odutayo A, Hladunewich M. Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol. 2012;7(12):2073–80.

    Article  PubMed  Google Scholar 

  43. Wolf J, Gerlach N, Weber K, et al. The diagnostic relevance of NT-proBNP and proANP 31–67 measurements in staging of myxomatous mitral valve disease in dogs. Vet Clin Pathol. 2013;42(2):196–206.

    Article  PubMed  Google Scholar 

  44. Misbach C, Chetboul V, Concordet D, et al. Basal plasma concentrations of N-terminal pro-B-type natriuretic peptide in clinically healthy adult small size dogs: effect of body weight, age, gender and breed, and reference intervals. Res Vet Sci. 2013;95(3):879–85.

    Article  CAS  PubMed  Google Scholar 

  45. Chang AY, Abdullah SM, Jain T, et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol. 2007;49(1):109–16.

    Article  CAS  PubMed  Google Scholar 

  46. Fragopoulu E, Panagiotakos DB, Pitsavos C, et al. N-terminal ProBNP distribution and correlations with biological characteristics in apparently healthy greek population: ATTICA study. Angiology. 2010;61(4):397–404.

    Article  Google Scholar 

  47. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976–82.

    Article  CAS  PubMed  Google Scholar 

  48. Loke I, Squire IB, Davies JE, et al. Reference ranges for natriuretic peptides for diagnostic use are dependenton age, gender and heart rate. Eur J Heart Fail. 2003;5(5):599–606.

    Article  CAS  PubMed  Google Scholar 

  49. Sutton TM, Stewart RAH, Gerber IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol. 2003;41(12):2280–7.

    Article  CAS  PubMed  Google Scholar 

  50. Lam CSP, Cheng S, Choong K, et al. Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol. 2011;58(6):618–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Hong M, Yan Q, Tao B, et al. Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats. Biol Chem Hoppe Seyler. 1992;373(4):213–8.

    Article  CAS  PubMed  Google Scholar 

  52. Maffei S, Del Ry S, Prontera C, et al. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clin Sci (Lond). 2001;101(5):447–53.

    Article  CAS  PubMed  Google Scholar 

  53. Deng Y, Kaufman S. The influence of reproductive hormones on ANF release by rat atria. Life Sci. 1993;53(9):689–96.

    Article  CAS  PubMed  Google Scholar 

  54. Maffei S, Clerico A, Iervasi G, et al. Circulating levels of cardiac natriuretic hormones measured in women during menstrual cycle. J Endocrinol Invest. 1999;22(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  55. Yeko TR, Rao PS, Parsons AK, et al. Atrial natriuretic peptide, oestradiol and progesterone in women undergoing spontaneous and gonadotrophin-stimulated ovulatory cycles. Hum Reprod. 1995;10(11):2872–4.

    Article  CAS  PubMed  Google Scholar 

  56. Jensen LK, Svanegaard J, Husby H. Atrial natriuretic peptide during the menstrual cycle. Am J Obstet Gynecol. 1989;161(4):951–2.

    Article  CAS  PubMed  Google Scholar 

  57. Ames MK, Atkins CE, Lee S, et al. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs. Am J Vet Res. 2015;76(12):1041–50.

    Article  CAS  PubMed  Google Scholar 

  58. Sallsten G, Barregard L. Variability of urinary creatinine in healthy individuals. Int J Environ Res Public Health. 2021;18(6):3166.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Mochel JP, Fink M, Peyrou M, et al. Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology. Chronobiol Int. 2013;30(9):1144–59.

    Article  CAS  PubMed  Google Scholar 

  60. Kenee BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127–40.

    Article  Google Scholar 

  61. Acierno MJ, Brown S, Coleman AE, et al. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med. 2018;32:1803–22.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Thomas WP, Gaber CE, Jacobs GJ, et al. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, american college of veterinary internal medicine. J Vet Intern Med. 1993;7:247–52.

    Article  CAS  PubMed  Google Scholar 

  63. IRIS Canine GN Study Group Standard Therapy Subgroup, Brown S, Elliott J, Francey T, et al. Consensus recommendations for standard therapy of glomerular disease in dogs. J Vet Intern Med. 2013;27:27–S43.

    Article  Google Scholar 

  64. Brugger N, Otzdorff C, Walter B, et al. Quantitative determination of progesterone (P4) in canine blood serum using an enzyme-linked fluorescence assay. Reprod Domest Anim. 2011;46(5):870–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

LINEA2 CLOCC_2020 A (University of Milan internal research fund). APC central fund of the University of Milan. The funding bodies played no role in the design of the study and collection, analysis, interpretation of data, and in writing the manuscript.

Author information

Authors and Affiliations

  1. Department of Veterinary Medicine and Animal Science, University of Milan, Via dell’Università 6, Lodi, 26900, Italy

    Alberto Galizzi, Greta Dossi, Vitaliano Borromeo, Paola Pocar, Debora Groppetti & Chiara Locatelli

Authors
  1. Alberto Galizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Greta Dossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vitaliano Borromeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paola Pocar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Debora Groppetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chiara Locatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors participated in the conception and design of the study. AG, CL, DG and GD acquired clinical data. AG and GD drafted the manuscript. CL was involved in critically revising the manuscript. VB, PP and DG performed laboratory analysis. AG and CL performed statistical analysis. The authors have read and approved the final manuscript.

Corresponding author

Correspondence to Alberto Galizzi.

Ethics declarations

Ethics approval and consent to participate

The study was conducted in accordance with guidelines of the Animal Welfare Organisation of the Università degli Studi di Milano (approval number 2/ 2016) and with informed consent of the owners. The present study was part of the research project “Identification of breed-specific reference values for echocardiographic parameters and neurohormonal biomarkers in Chihuahua breed”, approved by the Animal Welfare Organisation of the Università degli Studi di Milano (OPBA_88_2021). The study is reported in accordance with ARRIVE guidelines.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galizzi, A., Dossi, G., Borromeo, V. et al. Aldosterone-progesterone relationship in sexually intact Chihuahua bitches. BMC Vet Res 19, 144 (2023). https://doi.org/10.1186/s12917-023-03704-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12917-023-03704-2

Keywords

BMC Veterinary Research

ISSN: 1746-6148

Contact us